Friday, December 31, 2021 11:44:34 AM
2.2.4.1 Seller has furnished or made available to Buyer, or will make available to Buyer prior to the Closing, true and complete copies of the financial statements of The CareClix Group for the its past two (2019 and 2020) fiscal years or such lesser periods as any member of the CareClix Group has been in operation, (the “The CareClix Group Financial Statement”), and Seller shall furnish or make available to Buyer true and complete copies of The CareClix Group's financial statements for all monthly periods ending after its most recent fiscal year up to and including the Closing.
2.2.4.2 The CareClix Group Financial Statements were prepared in accordance with accounting rules applied on a basis consistent throughout the periods indicated (except as otherwise stated in such financial statements, including the related notes, and except that, in the case of unaudited financial statements for the subsequent quarterly periods referenced above, such unaudited financial statements fairly present in all material respects the consolidated financial condition and the results of operations of The CareClix Group as at the respective dates thereof and for the periods indicated therein
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM